medline.ch Onkologie Respirationstrakt

	Enhancing the Diagnostic Performance of Early Lung Cancer by Integrating Multiplex Nucleic Acid Aptamer Detection With Conventional Tumor Markers: A Prospective Observational Study. Am J Clin Oncol Yuan H, Wang W, Wei Z, Zhang L, Lu D, Liu Y, He K, Wang T, Liao S. PMID: 41810845 [PubMed - as supplied by publisher]
	Personalised screening intensity based on existing lung cancer risk and spirometry. ERJ Open Res Goodley P, Zahed H, Balata H, Alonso A, Sharman A, Merchant Z, Hewitt K, Booton R, Sperrin M, Robbins HA, Crosbie PAJ. PMID: 41809861 [PubMed]
	Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy. Clin Transl Radiat Oncol Filippi AR, Bar J, Christoph DC, Field JK, Fietkau R, Garassino MC, Garrido P, Haakensen VD, Kao S, McDonald F, Mornex F, Moskovitz M, Peters S, Van Den Heuvel MM, Vercauter P, Smit HJM, Solomon B, Chander P, Qiao Y, Faria J, Girard N. PMID: 41809542 [PubMed]
	Comparative effectiveness of robotic and video assisted thoracic surgery for lung cancer across key outcomes. iScience Shen G, Wang R, Xu J, Chen J, Chen R, Wang Y, Zhang X, Wang K, Dai Y, Li J. PMID: 41809046 [PubMed]
	Current advances in mediastinal staging for non-small cell lung cancer: a narrative review. Transl Lung Cancer Res Minervini F, Grünig H, Kestenholz P, Gaisl T, Lampridis S. PMID: 41808716 [PubMed]
	Osimertinib opens the door for patients with EGFR-mutated advanced non-small cell lung cancer and a poor performance status: comment on the OPEN/TORG2040 trial. Transl Lung Cancer Res Fukui T, Naoki K. PMID: 41808710 [PubMed]
	Predictive modeling of immunotherapy efficacy in driver gene-negative non-small cell lung cancer. Transl Lung Cancer Res Tao X, Chen Y, Zhong Y, Liu X, Zou G, Zhou X, Luo H. PMID: 41808703 [PubMed]
	Review of patient-reported outcomes in EMPOWER-Lung 1 in patients with advanced non-small cell lung cancer treated with cemiplimab versus chemotherapy. Cancer Gandara DR, Gümü, Kilickap S, Sezer A, Bondarenko I, Özgüro, Gogishvili M, Yan E, Jia X, Kim E, Seebach F, Quek RGW. PMID: 41808570 [PubMed - in process]
	Methylation signatures distinguish non small cell lung cancer subtypes and associated with survival in smokers with lung squamous cell carcinoma. J Natl Cancer Inst Lim H, Byun J, Ripley RT, Choi J, Cheng C, Thrift AP, Han Y, Amos CI. PMID: 41808476 [PubMed - as supplied by publisher]
	Unraveling lung cancer dynamics: a new metabolic signature improving the prediction of recurrence in resected lung adenocarcinoma. J Transl Med Jacobs F, Manganaro L, D'Ambrosio L, Corà D, Olivero M, Napoli F, Filippis M, Cetoretta V, Garbo E, Mele T, Arigoni M, Zanella ER, Parab S, Munir HMW, Picca F, Taulli R, Bersani F, Merlini A, Calogero R, Trusolino L, Primo L, Righi L, Volante M, Leo F, Ruffini E, Papotti M, Bussolino F, Novello S, Scagliotti GV, Bironzo P, Doronzo G. PMID: 41808183 [PubMed - as supplied by publisher]
	Systemic therapy outcomes following separation surgery versus maximal feasible resection for spinal metastases from non-small cell lung cancer: a real-world retrospective cohort study. World J Surg Oncol Shen Z, Wang P, Yuan H, Li B, Xiao J, Xu W. PMID: 41808173 [PubMed - as supplied by publisher]
	Healthcare professionals' perspectives on a population-based lung cancer screening programme in Flanders: a cross-sectional survey study. BMC Health Serv Res Michiels L, Verlies C, Dooms C, Van Hal G, Huys I. PMID: 41808139 [PubMed - as supplied by publisher]
	T Cell Exhaustion: Phenomenon, Diagnostic and Prognostic Significance, Age-Related Features, and Correction in Lung Cancer. Bull Exp Biol Med Skurikhin EG, Zhukova MA, Pan ES, Ermakova NN, Zharkikh IL, Dygai AM. PMID: 41807863 [PubMed - as supplied by publisher]
	A lightweight CNN for enhanced non-small cell lung cancer classification using CT scan image. Sci Rep Baqir MA, Qayyum S, Ashfaq N, Li J, Wang Y, Mahmood T, Saba T. PMID: 41807468 [PubMed - as supplied by publisher]
	Efficacy and safety of a low-dose nivolumab regimen (240Â mg) as neoadjuvant immunochemotherapy in Chinese patients with resectable non-small cell lung cancer: a prospective single-arm, exploratory study. Int Immunopharmacol Cheng Z, Ai Y, Lin Y, Wu Y, Nie S, Yu Z, Zou J. PMID: 41806690 [PubMed - as supplied by publisher]
	Volume and location of screen-detected lung nodules associated with lung cancer within two-year follow-up: Post hoc analysis from the UK Lung Cancer Screening (UKLS) trial. Lung Cancer Asmara OD, Lancaster HL, Field JK, Davies MPA, Duffy SW, Boerma EC, Visser E, de Jong K, Devaraj A, Heuvelmans MA, van Geffen WH, Oudkerk M. PMID: 41806497 [PubMed - as supplied by publisher]
	Neonatal primary pulmonary neoplasms, clinical, imaging, and differential diagnosis. Pediatr Radiol Newman B. PMID: 41805992 [PubMed - as supplied by publisher]
	How exclusion criteria can hinder eligibility for lung cancer studies among different racial and ethnic groups. PLOS Digit Health Kim JY, Dirks A, Ford RM, Pai L, Ludwig C, Tapan U. PMID: 41805924 [PubMed]
	Accuracy and reproducibility of tumor size measurement using a deep-learning-based CDSS in resected lung cancer. PLoS One Kim EY, Kim JS, Jin KN, Cho YJ, Kim JY. PMID: 41805778 [PubMed - indexed for MEDLINE]
	Advancing lung cancer therapy - leveraging cell biology to improve immunotherapy and anti-angiogenic strategies. J Cell Sci Haj-Shomaly J, Castillo-Kauil A, Bloom C, Hodivala-Dilke KM, D'Amico G. PMID: 41805114 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 157015

Seite 1 von 7851

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung